Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
0.610
-0.020 (-3.17%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Barinthus Biotherapeutics Employees
Barinthus Biotherapeutics had 14 employees as of December 31, 2025. The number of employees decreased by 91 or -86.67% compared to the previous year.
Employees
14
Change (1Y)
-91
Growth (1Y)
-86.67%
Revenue / Employee
n/a
Profits / Employee
-$4,744,857
Market Cap
24.92M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Longeveron | 38 |
| Jasper Therapeutics | 22 |
| ABVC BioPharma | 19 |
| Quantum BioPharma | 17 |
| NeuroSense Therapeutics | 17 |
| Lantern Pharma | 16 |
| AEON Biopharma | 8 |
| NanoViricides | 7 |
BRNS News
- 6 months ago - ChemDiv Continues R&D Services Support for Clywedog Therapeutics Following Merger with Barinthus Therapeutics - PRNewsWire
- 7 months ago - BARINTHUS BIOTHERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Barinthus Biotherapeutics plc - BRNS - Business Wire
- 7 months ago - Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases - GlobeNewsWire
- 11 months ago - Barinthus Biotherapeutics' CEO Bill Enright to Present at the Investor Summit Virtual on June 10, 2025 - Accesswire
- 1 year ago - Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments - GlobeNewsWire
- 1 year ago - Barinthus Biotherapeutics plc to Present at the Investor Summit Virtual on March 11 - Accesswire
- 1 year ago - Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update - GlobeNewsWire
- 1 year ago - Barinthus Bio Promotes SNAP-TI Co-inventor, Geoffrey Lynn, M.D., Ph.D. to Chief Scientific Officer - GlobeNewsWire